Product Introduction: TELKONOL 80 H

TELKONOL 80 H is a widely prescribed high-strength combination anti-hypertensive medication manufactured by Knoll. Composed of 80mg of Telmisartan (an angiotensin II receptor blocker) and 12.5mg of Hydrochlorothiazide (a thiazide diuretic), it is indicated for the treatment of essential hypertension when lower doses are insufficient, lowering blood pressure and reducing cardiovascular risks.

Primary Indications

• Treatment of essential hypertension (high blood pressure).
• Prevention of cardiovascular disease, reducing stroke and heart attack risk.
• Management of hypertension in patients with left ventricular hypertrophy.

Clinical Benefits

• Dual Action: Telmisartan relaxes blood vessels, while Hydrochlorothiazide promotes water excretion, lowering blood pressure.
• Cardioprotection: Significantly reduces cardiac preload and afterload, protecting against heart failure.
• Once-Daily Convenience: Offers reliable 24-hour blood pressure control with a single daily tablet.

Possible Side Effects

Common side effects may include:

• Dizziness, fatigue, headache, or orthostatic hypotension.
• Electrolyte imbalances, such as hypokalemia or hyponatremia.
• Mild gastrointestinal discomfort or transient renal impairment.

How to Take TELKONOL 80 H

• Take one tablet daily, with or without food, preferably in the morning.
• Swallow the tablet whole with a glass of water.
• Do not stop taking the drug abruptly, as blood pressure can rise quickly.

Mechanism of Action

TELKONOL 80 H works through two distinct mechanisms:

• Telmisartan: Selectively blocks the angiotensin II AT1 receptor, inhibiting vasoconstriction and aldosterone release, causing blood vessels to dilate.
• Hydrochlorothiazide: Inhibits sodium and chloride reabsorption in the distal convoluted tubules, increasing water and salt excretion.

Safety Warnings

• Pregnancy & Nursing: Strictly contraindicated. Angiotensin blockers can cause fetal injury or death.
• Liver Health: Since Telmisartan is extensively cleared by bile, use with caution in hepatic impairment.
• Kidney Health: Monitor renal function regularly, especially in patients with renal artery stenosis.

Patient Advice

• Avoid standing up too quickly from a sitting or lying position to prevent dizziness.
• Monitor your blood pressure regularly and keep a record.
• Avoid potassium supplements or salt substitutes unless directed by your physician.

Fact Box

Drug Interactions

• Lithium: Diuretics decrease lithium clearance, increasing toxicity risk.
• NSAIDs (Ibuprofen): May reduce the blood-pressure-lowering effect.
• Potassium-Sparing Diuretics: May cause severe hyperkalemia.

User Feedback

• Patients report highly satisfactory blood pressure control, with a significant reduction in dizziness.
• Highly recommended by clinicians as a reliable combination therapy for essential hypertension.